These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34661081)

  • 1. Covalently Loaded Naloxone Nanoparticles as a Long-Acting Medical Countermeasure to Opioid Poisoning.
    Kassick AJ; Wu M; Luengas D; Ebqa'ai M; Tharika Nirmani LP; Tomycz N; Nelson TL; Pravetoni M; Raleigh MD; Averick S
    ACS Pharmacol Transl Sci; 2021 Oct; 4(5):1654-1664. PubMed ID: 34661081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Oral Nanoparticle Formulation of Sustained Release Naloxone with Mild Withdrawal Symptoms in Mice.
    Madison CA; Arora M; Kumar MNVR; Eitan S
    ACS Chem Neurosci; 2020 Jul; 11(13):1955-1964. PubMed ID: 32491828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent Poly(lactic acid) Nanoparticles for the Sustained Delivery of Naloxone.
    Kassick AJ; Allen HN; Yerneni SS; Pary F; Kovaliov M; Cheng C; Pravetoni M; Tomycz ND; Whiting DM; Nelson TL; Feasel M; Campbell PG; Kolber B; Averick S
    ACS Appl Bio Mater; 2019 Aug; 2(8):3418-3428. PubMed ID: 31497753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and preliminary evaluation of a potential synthetic opioid rescue agent.
    Hedrick SL; Luo D; Kaska S; Niloy KK; Jackson K; Sarma R; Horn J; Baynard C; Leggas M; Butelman ER; Kreek MJ; Prisinzano TE
    J Biomed Sci; 2021 Sep; 28(1):62. PubMed ID: 34503531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methocinnamox Reverses and Prevents Fentanyl-Induced Ventilatory Depression in Rats.
    Jimenez VM; Castaneda G; France CP
    J Pharmacol Exp Ther; 2021 Apr; 377(1):29-38. PubMed ID: 33431611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial.
    Zamani N; Buckley NA; Hassanian-Moghaddam H
    Crit Care; 2020 Feb; 24(1):44. PubMed ID: 32033582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal delivery of Naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose.
    Hasan N; Imran M; Kesharwani P; Khanna K; Karwasra R; Sharma N; Rawat S; Sharma D; Ahmad FJ; Jain GK; Bhatnagar A; Talegaonkar S
    Int J Pharm; 2021 Apr; 599():120428. PubMed ID: 33662465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Translational Model to Assess the Impact of Opioid Overdose and Naloxone Dosing on Respiratory Depression and Cardiac Arrest.
    Mann J; Samieegohar M; Chaturbedi A; Zirkle J; Han X; Ahmadi SF; Eshleman A; Janowsky A; Wolfrum K; Swanson T; Bloom S; Dahan A; Olofsen E; Florian J; Strauss DG; Li Z
    Clin Pharmacol Ther; 2022 Nov; 112(5):1020-1032. PubMed ID: 35766413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments.
    Miner NB; Schutzer WE; Zarnegarnia Y; Janowsky A; Torralva R
    Drug Alcohol Depend; 2021 Oct; 227():108974. PubMed ID: 34492557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal Antibodies for Combating Synthetic Opioid Intoxication.
    Smith LC; Bremer PT; Hwang CS; Zhou B; Ellis B; Hixon MS; Janda KD
    J Am Chem Soc; 2019 Jul; 141(26):10489-10503. PubMed ID: 31187995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox.
    Zamora JC; Smith HR; Jennings EM; Chavera TS; Kotipalli V; Jay A; Husbands SM; Disney A; Berg KA; Clarke WP
    Pharmacol Res Perspect; 2021 Dec; 9(6):e00887. PubMed ID: 34713624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid-induced respiratory effects: new data on buprenorphine.
    Dahan A
    Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E; Neruda B; Smith OW
    Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Injectable Naloxone-Releasing Hydrogels.
    Crowe KM; Siddiqui Z; Harbour V; Kim K; Syed S; Paul R; Roy A; Naik R; Mitchell K; Mahajan A; Sarkar B; Kumar VA
    ACS Appl Bio Mater; 2020 Nov; 3(11):7858-7864. PubMed ID: 35019526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level.
    Moss RB; Pryor MM; Baillie R; Kudrycki K; Friedrich C; Reed M; Carlo DJ
    PLoS One; 2020; 15(6):e0234683. PubMed ID: 32544184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overdoses due to fentanyl and its analogues (F/FAs) push naloxone to the limit.
    Pergolizzi JV; Dahan A; Ann LeQuang J; Raffa RB
    J Clin Pharm Ther; 2021 Dec; 46(6):1501-1504. PubMed ID: 34111307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prepacked naloxone administration for suspected opioid overdose in the era of illicitly manufactured fentanyl: a retrospective study of regional poison center data.
    Mahonski SG; Leonard JB; Gatz JD; Seung H; Haas EE; Kim HK
    Clin Toxicol (Phila); 2020 Feb; 58(2):117-123. PubMed ID: 31092050
    [No Abstract]   [Full Text] [Related]  

  • 18. Opioid Antagonists from the Orvinol Series as Potential Reversal Agents for Opioid Overdose.
    Disney A; Olson KM; Shafer AM; Moore SC; Anand JP; Traynor JR; Husbands SM
    ACS Chem Neurosci; 2022 Nov; 13(21):3108-3117. PubMed ID: 36223082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding preference at the μ-opioid receptor underlies distinct pharmacology of cyclopropyl versus valeryl analogs of fentanyl.
    Xie B; Le Rouzic VP; Goldberg A; Tsai MM; Chen L; Zhang T; Sinha A; Pan YX; Baumann MH; Shi L
    Neuropharmacology; 2023 Apr; 227():109442. PubMed ID: 36731721
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.